Titus-Lay Erika, Nehira Jeffrey, Courtney Jennifer, Jee Jacquelyn, Kumar Marissa, Tiet Jenny, Le Vivi, Durbin-Johnson Blythe, Chen Moon S, Vinall Ruth
California Northstate University College of Pharmacy (CNUCOP), Elk Grove, CA 95757, USA.
Department of Public Health Sciences, School of Medicine, University of California Davis, One Shields Avenue, Davis, CA 95616, USA.
Explor Res Clin Soc Pharm. 2023 Jul 13;11:100311. doi: 10.1016/j.rcsop.2023.100311. eCollection 2023 Sep.
The goals of this cross-sectional community-based survey study were to assess the impact of the Covid-19 pandemic on actionable factors which are known to contribute to worse cancer outcomes, and to determine whether race and ethnicity-based differences exist.
A survey study which captured demographic information and changes in cancer outcomes-related factors since the start of the Covid-19 pandemic, was conducted at a public Covid-19 vaccination clinic over a period of 10 days during March 2021. Surveys were administered in multiple languages. Chi-square tests and ANOVA followed by post-hoc Dunnett testing assessed for race and ethnicity-based differences.
A total of 949 people participated (61.6% participation rate). Ninety-three surveys were removed based on inclusion criteria giving a final participant number of 856. Many participants reported postponing cancer screenings (17.8%) and cancellation of medical appointments (22.8% and 25.8% reported cancelled appointments by providers or themselves, respectively) due to the pandemic. Participants also reported decreased physical activity (44.7%) and increased tobacco and/or marijuana usage (7.0%). Conversely, participants reported consuming more fruits and vegetables (21.4%) and decreasing alcohol consumption (21.4%). Several race-related differences but no ethnicity-related differences were observed.
Our data can be used to help guide pharmacist-led targeted outreach in our community which will help mitigate Covid-19 pandemic-driven changes in behaviors associated with worse cancer outcomes and exacerbation of cancer health disparities. To our knowledge, this is the first cancer outcomes-related study to be conducted at a public Covid-19 vaccination site and is the first pharmacist-led study in this area.
这项基于社区的横断面调查研究的目标是评估新冠疫情对已知会导致更差癌症预后的可采取行动因素的影响,并确定是否存在基于种族和民族的差异。
2021年3月,在一家公共新冠疫苗接种诊所进行了一项调查研究,该研究收集了自新冠疫情开始以来的人口统计学信息以及癌症预后相关因素的变化。调查以多种语言进行。采用卡方检验和方差分析,随后进行事后邓尼特检验来评估基于种族和民族的差异。
共有949人参与(参与率为61.6%)。根据纳入标准剔除了93份调查问卷,最终参与者人数为856人。许多参与者报告称,由于疫情,他们推迟了癌症筛查(17.8%),取消了医疗预约(分别有22.8%和25.8%的参与者报告称是由医疗服务提供者或他们自己取消了预约)。参与者还报告称身体活动减少(44.7%),烟草和/或大麻使用增加(7.0%)。相反,参与者报告称食用了更多水果和蔬菜(21.4%),饮酒量减少(21.4%)。观察到了一些与种族相关的差异,但未观察到与民族相关的差异。
我们的数据可用于帮助指导社区中由药剂师主导的有针对性的宣传活动,这将有助于减轻新冠疫情导致的与更差癌症预后相关的行为变化以及癌症健康差距的加剧。据我们所知,这是在公共新冠疫苗接种点进行的第一项与癌症预后相关的研究,也是该领域第一项由药剂师主导的研究。